Literature DB >> 23908903

Molecular characterization of NDM-1 producing Enterobacteriaceae isolates in Singapore hospitals.

Jeanette Teo1, Grace Ngan, Michelle Balm, Roland Jureen, Prabha Krishnan, Raymond Lin.   

Abstract

OBJECTIVE: In this study, we molecularly characterized 12 NDM-1 producing clinical Enterobacteriaceae (Klebsiella pneumoniae, Escherichia coli, Enterobacter cloacae) isolates that were part of a collection of non-carbapenem susceptible isolates obtained during a one-year period. These isolates were obtained from four local general hospitals in Singapore.
METHODS: Polymerase chain reaction (PCR) assays and sequencing was used to determine the presence of β-lactamase encoding genes (bla) including bla NDM-1 and plasmid-mediated quinolone and aminoglycoside resistance determinants. Conjugation experiments were performed to determine the transferability of bla NDM-1. Isolate relatedness was determined by multilocus sequence typing (MLST).
RESULTS: The isolates were completely resistant to the second- and third-generation cephalosporins tested as well as carbapenems. Susceptibility profiling of the isolates indicated that 100% retained susceptibility to tigecycline while 11/12 (91.7%) were susceptible to colistin. The bla NDM-1 gene was encoded on plasmids that were easily transferable. None of the patients had a travel history to countries where NDM-1 has been reported. The isolates appear clonally unrelated with MLST, revealing a diversity of clonal types among the Klebsiella pneumoniae and Escherichia coli isolates.
CONCLUSION: The ease of NDM-1 plasmid transmissibility may help their dissemination among the Enterobacteriaceae. Although it appears that the isolates are clonally unrelated, epidemiological links cannot be fully excluded without further research.

Entities:  

Year:  2012        PMID: 23908903      PMCID: PMC3729072          DOI: 10.5365/WPSAR.2011.2.4.010

Source DB:  PubMed          Journal:  Western Pac Surveill Response J        ISSN: 2094-7321


  16 in total

1.  Global spread of New Delhi metallo-β-lactamase 1.

Authors:  Tse Hsien Koh; Cheng Teng Khoo; Limin Wijaya; Hoe Nam Leong; Yew Long Lo; Lay Cheng Lim; Tse Yuen Koh
Journal:  Lancet Infect Dis       Date:  2010-12       Impact factor: 25.071

2.  NDM-1--a cause for worldwide concern.

Authors:  Robert C Moellering
Journal:  N Engl J Med       Date:  2010-12-16       Impact factor: 91.245

Review 3.  Molecular understanding of aminoglycoside action and resistance.

Authors:  S Jana; J K Deb
Journal:  Appl Microbiol Biotechnol       Date:  2006-01-04       Impact factor: 4.813

4.  Identification of 16S rRNA methylase-producing Acinetobacter baumannii clinical strains in North America.

Authors:  Yohei Doi; Jennifer M Adams; Kunikazu Yamane; David L Paterson
Journal:  Antimicrob Agents Chemother       Date:  2007-09-04       Impact factor: 5.191

5.  A set of multiplex PCRs for genotypic detection of extended-spectrum β-lactamases, carbapenemases, plasmid-mediated AmpC β-lactamases and OXA β-lactamases.

Authors:  Guido M Voets; A C Fluit; Jelle Scharringa; James Cohen Stuart; Maurine A Leverstein-van Hall
Journal:  Int J Antimicrob Agents       Date:  2011-02-25       Impact factor: 5.283

6.  Identification of plasmids by PCR-based replicon typing.

Authors:  Alessandra Carattoli; Alessia Bertini; Laura Villa; Vincenzo Falbo; Katie L Hopkins; E John Threlfall
Journal:  J Microbiol Methods       Date:  2005-06-02       Impact factor: 2.363

7.  Emergence of metallo-β-lactamase NDM-1-producing multidrug-resistant Escherichia coli in Australia.

Authors:  Laurent Poirel; Emilie Lagrutta; Peter Taylor; Jeanette Pham; Patrice Nordmann
Journal:  Antimicrob Agents Chemother       Date:  2010-09-07       Impact factor: 5.191

8.  Dissemination of NDM-1 positive bacteria in the New Delhi environment and its implications for human health: an environmental point prevalence study.

Authors:  Timothy R Walsh; Janis Weeks; David M Livermore; Mark A Toleman
Journal:  Lancet Infect Dis       Date:  2011-04-07       Impact factor: 25.071

9.  Emergence of a new antibiotic resistance mechanism in India, Pakistan, and the UK: a molecular, biological, and epidemiological study.

Authors:  Karthikeyan K Kumarasamy; Mark A Toleman; Timothy R Walsh; Jay Bagaria; Fafhana Butt; Ravikumar Balakrishnan; Uma Chaudhary; Michel Doumith; Christian G Giske; Seema Irfan; Padma Krishnan; Anil V Kumar; Sunil Maharjan; Shazad Mushtaq; Tabassum Noorie; David L Paterson; Andrew Pearson; Claire Perry; Rachel Pike; Bhargavi Rao; Ujjwayini Ray; Jayanta B Sarma; Madhu Sharma; Elizabeth Sheridan; Mandayam A Thirunarayan; Jane Turton; Supriya Upadhyay; Marina Warner; William Welfare; David M Livermore; Neil Woodford
Journal:  Lancet Infect Dis       Date:  2010-08-10       Impact factor: 25.071

Review 10.  Mechanism of action of and resistance to quinolones.

Authors:  Anna Fàbrega; Sergi Madurga; Ernest Giralt; Jordi Vila
Journal:  Microb Biotechnol       Date:  2008-10-13       Impact factor: 5.813

View more
  26 in total

1.  In Vitro Activities of Ceftazidime-Avibactam, Aztreonam-Avibactam, and a Panel of Older and Contemporary Antimicrobial Agents against Carbapenemase-Producing Gram-Negative Bacilli.

Authors:  Shawn Vasoo; Scott A Cunningham; Nicolynn C Cole; Peggy C Kohner; Sanjay R Menon; Kevin M Krause; Kelly A Harris; Partha P De; Tse Hsien Koh; Robin Patel
Journal:  Antimicrob Agents Chemother       Date:  2015-09-21       Impact factor: 5.191

2.  Unusual detection of an Acinetobacter class D carbapenemase gene, blaOXA-23, in a clinical Escherichia coli isolate.

Authors:  My-Van La; Roland Jureen; Raymond T P Lin; Jeanette W P Teo
Journal:  J Clin Microbiol       Date:  2014-07-16       Impact factor: 5.948

3.  Detection of New Delhi Metallo-Beta-Lactamase-1 (NDM-1) in carbapenem- resistant Klebsiella pneumoniae isolated from a university hospital in Iran.

Authors:  H Fazeli; M Norouzi-Barough; A M Ahadi; D Shokri; H Solgi
Journal:  Hippokratia       Date:  2015 Jul-Sep       Impact factor: 0.471

4.  Aztreonam-Avibactam Combination Restores Susceptibility of Aztreonam in Dual-Carbapenemase-Producing Enterobacteriaceae.

Authors:  Ka Lip Chew; Michelle K L Tay; Bernadette Cheng; Raymond T P Lin; Sophie Octavia; Jeanette W P Teo
Journal:  Antimicrob Agents Chemother       Date:  2018-07-27       Impact factor: 5.191

Review 5.  Ten-year narrative review on antimicrobial resistance in Singapore.

Authors:  Alvin Qijia Chua; Andrea Lay-Hoon Kwa; Thean Yen Tan; Helena Legido-Quigley; Li Yang Hsu
Journal:  Singapore Med J       Date:  2019-08       Impact factor: 1.858

6.  Molecular Epidemiology of Colistin-Resistant, Carbapenemase-Producing Klebsiella pneumoniae in Serbia from 2013 to 2016.

Authors:  Katarina Novović; Anika Trudić; Snežana Brkić; Zorica Vasiljević; Milan Kojić; Deana Medić; Ivana Ćirković; Branko Jovčić
Journal:  Antimicrob Agents Chemother       Date:  2017-04-24       Impact factor: 5.191

7.  Colistin and Polymyxin B Susceptibility Testing for Carbapenem-Resistant and mcr-Positive Enterobacteriaceae: Comparison of Sensititre, MicroScan, Vitek 2, and Etest with Broth Microdilution.

Authors:  Ka Lip Chew; My-Van La; Raymond T P Lin; Jeanette W P Teo
Journal:  J Clin Microbiol       Date:  2017-06-07       Impact factor: 5.948

8.  In Vitro Activity of Imipenem-Relebactam and Ceftolozane-Tazobactam against Resistant Gram-Negative Bacilli.

Authors:  Suzannah M Schmidt-Malan; Avisya J Mishra; Ammara Mushtaq; Cassandra L Brinkman; Robin Patel
Journal:  Antimicrob Agents Chemother       Date:  2018-07-27       Impact factor: 5.191

9.  In Vitro Activity of Plazomicin Compared to Amikacin, Gentamicin, and Tobramycin against Multidrug-Resistant Aerobic Gram-Negative Bacilli.

Authors:  Wim A Fleischmann; Kerryl E Greenwood-Quaintance; Robin Patel
Journal:  Antimicrob Agents Chemother       Date:  2020-01-27       Impact factor: 5.191

10.  Antecedent Carbapenem Exposure as a Risk Factor for Non-Carbapenemase-Producing Carbapenem-Resistant Enterobacteriaceae and Carbapenemase-Producing Enterobacteriaceae.

Authors:  Kalisvar Marimuthu; Oon Tek Ng; Benjamin Pei Zhi Cherng; Raymond Kok Choon Fong; Surinder Kaur Pada; Partha Pratim De; Say Tat Ooi; Nares Smitasin; Koh Cheng Thoon; Prabha Unny Krishnan; Michelle Lay Teng Ang; Douglas Su Gin Chan; Andrea Lay Hoon Kwa; Rama Narayana Deepak; Yu Kit Chan; Yvonne Fu Zi Chan; Xiaowei Huan; Kyaw Zaw Linn; Nancy Wen Sim Tee; Thean Yen Tan; Tse Hsien Koh; Raymond Tzer Pin Lin; Li Yang Hsu; Sharmila Sengupta; David L Paterson; Eli Perencevich; Stephan Harbarth; Jeanette Teo; Indumathi Venkatachalam
Journal:  Antimicrob Agents Chemother       Date:  2019-09-23       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.